<DOC>
	<DOC>NCT01321931</DOC>
	<brief_summary>Multiple-dose nicotine pharmacokinetics with three oral nicotine replacement products. A study in healthy smokers.</brief_summary>
	<brief_title>Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products</brief_title>
	<detailed_description>Fifty (50) healthy male or female subjects between the ages of 19 and 50 years, inclusive, smoking at least 20 cigarettes daily during at least one year preceding inclusion. Multiple doses of all study treatments are given either every 60 minutes or every 90 minutes, respectively. All products will be administered in accordance with labeling, on five separate treatment visits. The subjects will abstain from smoking from 8 pm in the evening before and until the end of each visit.</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Healthy subjects, smoking at least 20 cigarettes daily during at least one year preceding inclusion. BMI between 17.5 and 30.0 kg/m2 and a total body weight of at least 55.0 kg. Female participants of childbearing potential are required to use a medically acceptable means of birth control. A personally signed and dated informed consent document, indicating that the subject has been informed of all pertinent aspects of the study. Willing and able to comply with all scheduled visits and study procedures Pregnancy, lactation or intended pregnancy. Treatment with an investigational product or donation or loss of blood within 3 month preceding the first dose of study medication. Any medical condition or history that might, per protocol or in the opinion of the investigator, compromise subject safety or trial results.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Smoking Cessation</keyword>
	<keyword>Nicotine pharmacokinetics</keyword>
</DOC>